These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24722394)

  • 1. Pharmacogenomics, lipid disorders, and treatment options.
    Gryn SE; Hegele RA
    Clin Pharmacol Ther; 2014 Jul; 96(1):36-47. PubMed ID: 24722394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and Statin Treatment: Reality or Theory?
    Bousoula E; Kolovou V; Perrea D; Kolovou G
    Curr Vasc Pharmacol; 2015; 13(5):616-23. PubMed ID: 25633365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation.
    Kim K; Bolotin E; Theusch E; Huang H; Medina MW; Krauss RM
    Genome Biol; 2014 Sep; 15(9):460. PubMed ID: 25316374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of Statin-Induced Myopathy: A Focused Review of the Clinical Translation of Pharmacokinetic Genetic Variants.
    Talameh JA; Kitzmiller JP
    J Pharmacogenomics Pharmacoproteomics; 2014 Apr; 5(2):. PubMed ID: 25221728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses.
    Brennan KS
    J Am Assoc Nurse Pract; 2015 May; 27(5):246-55. PubMed ID: 25755178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Human Genome Project, and recent advances in personalized genomics.
    Wilson BJ; Nicholls SG
    Risk Manag Healthc Policy; 2015; 8():9-20. PubMed ID: 25733939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.
    Edwards JG; Feldman G; Goldberg J; Gregg AR; Norton ME; Rose NC; Schneider A; Stoll K; Wapner R; Watson MS
    Obstet Gynecol; 2015 Mar; 125(3):653-662. PubMed ID: 25730230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals.
    Barajas MR; Formea CM; McCormick JB; Abdalrhim AD; Han LC; McBane RD; Fiksdal AS; Kullo IJ
    Curr Pharm Teach Learn; 2015; 7(2):249-255. PubMed ID: 25729462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the gap between knowledge and clinical application: challenges for genomic translation.
    Burke W; Korngiebel DM
    PLoS Genet; 2015; 11(2):e1004978. PubMed ID: 25719903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-shot, one cure with genome editing for dyslipidemia.
    Gupta RM
    Circ Cardiovasc Genet; 2014 Dec; 7(6):967-8. PubMed ID: 25516627
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome editing for human gene therapy.
    Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
    Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction.
    Leusink M; de Keyser CE; Onland-Moret NC; Hofman A; Visser LE; Stricker BH; de Bakker PI; de Boer A; van Schaik RH; Maitland-van der Zee AH
    Pharmacogenomics; 2014 Aug; 15(11):1471-7. PubMed ID: 25303298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of admixture and consanguinity on population genetic diversity in Middle East.
    Yang X; Al-Bustan S; Feng Q; Guo W; Ma Z; Marafie M; Jacob S; Al-Mulla F; Xu S
    J Hum Genet; 2014 Nov; 59(11):615-22. PubMed ID: 25253659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The revolution in human monogenic disease mapping.
    Duncan E; Brown M; Shore EM
    Genes (Basel); 2014 Sep; 5(3):792-803. PubMed ID: 25198531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular drugs and the genetic response.
    Dandona S
    Methodist Debakey Cardiovasc J; 2014; 10(1):13-7. PubMed ID: 24932357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
    Buchanan AH; Datta SK; Skinner CS; Hollowell GP; Beresford HF; Freeland T; Rogers B; Boling J; Marcom PK; Adams MB
    J Genet Couns; 2015 Dec; 24(6):961-70. PubMed ID: 25833335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counselors and Genomic Counseling in the United Kingdom.
    Middleton A; Hall G; Patch C
    Mol Genet Genomic Med; 2015 Mar; 3(2):79-83. PubMed ID: 25802877
    [No Abstract]   [Full Text] [Related]  

  • 18. Twenty-five years of breast cancer risk models and their applications.
    Gail MH
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25722355
    [No Abstract]   [Full Text] [Related]  

  • 19. Counseling and diagnostic evaluation for the infertile couple.
    Marshburn PB
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):1-14. PubMed ID: 25681836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.
    Berná G; Oliveras-López MJ; Jurado-Ruíz E; Tejedo J; Bedoya F; Soria B; Martín F
    Nutrients; 2014 Nov; 6(11):5338-69. PubMed ID: 25421534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.